EUVIMEDEUVIMED entdecken
Crossref

Depleting S100A4 in Cancer-Associated Fibroblasts Reverses Cisplatin Resistance in Esophageal Cancer

Haoqi Yu, Xu Ma, Ruiji Chen, Lei Miao iD, Zhihao Lu, Yingxue Lin, Yang Liu, Wenfu Zheng iD, Tianjiao Ji iD, Bo Yang

ACS Applied Bio Materials · 18.06.2026

DOI: 10.1021/acsabm.6c00573 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 18.06.2026. Verfasst von Haoqi Yu und 9 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience an…. Hauptthemen laut MEDLINE: Cisplatin, Esophageal Neoplasms, S100 Calcium-Binding Protein A4, Drug Resistance, Neoplasm. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Beijing Municipal Science and Technology Commission, National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinEsophageal NeoplasmsS100 Calcium-Binding Protein A4Drug Resistance, NeoplasmAntineoplastic AgentsCancer-Associated FibroblastsHumansAnimalsMiceDrug Screening Assays, AntitumorMice, NudeCell ProliferationParticle Size

Stichwörter der Autor:innen

S100A4cisplatin resistanceesophageal cancerlipid nanoparticlestumor-associated fibroblasts

Substanzen

CisplatinS100 Calcium-Binding Protein A4Antineoplastic AgentsS100A4 protein, human

Autor:innen und Institutionen

  • CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.
  • University of Chinese Academy of Sciences, Beijing 101408, China.
  • Department of Thoracic Surgery, the First Medical Center of Chinese PLA General Hospital, Beijing 100853, China.
  • State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education, Beijing), Peking University Cancer Hospital and Institute, Beijing 100142, China.
  • School of Medicine, Nankai University, Tianjin 300071, China.

ORCID-Profile: Lei Miao, Wenfu Zheng, Tianjiao Ji

Förderung

  • Beijing Municipal Science and Technology Commission
  • National Natural Science Foundation of China (NSFC)

Zitieren

APA

Yu, H., Ma, X., Chen, R., Miao, L., Lu, Z., Lin, Y., Liu, Y., Zheng, W., Ji, T., & Yang, B. (2026). Depleting S100A4 in Cancer-Associated Fibroblasts Reverses Cisplatin Resistance in Esophageal Cancer. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.6c00573

Vancouver

Yu H, Ma X, Chen R, Miao L, Lu Z, Lin Y, et al. Depleting S100A4 in Cancer-Associated Fibroblasts Reverses Cisplatin Resistance in Esophageal Cancer. ACS Applied Bio Materials. 2026. doi:10.1021/acsabm.6c00573

BibTeX
@article{Yu2026,
  author = {Yu, Haoqi and Ma, Xu and Chen, Ruiji and Miao, Lei and Lu, Zhihao and Lin, Yingxue and Liu, Yang and Zheng, Wenfu and Ji, Tianjiao and Yang, Bo},
  title = {Depleting S100A4 in Cancer-Associated Fibroblasts Reverses Cisplatin Resistance in Esophageal Cancer},
  journal = {ACS Applied Bio Materials},
  year = {2026},
  doi = {10.1021/acsabm.6c00573}
}
Kostenlos starten →